Trial Profile
Study to evaluate the treatment adherence in patients treated with Ticagrelor after placement of Drug Eluting Stent
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2017
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Stent thrombosis
- Focus Therapeutic Use
- 29 Jun 2017 New trial record